Atta Behfar (@attabehfar) 's Twitter Profile
Atta Behfar

@attabehfar

Regenerative Medicine and Heart Transplant at Mayo Clinic
Founder of Rion Inc.

ID: 994576220988891136

calendar_today10-05-2018 13:53:44

17 Tweet

251 Followers

44 Following

Atta Behfar (@attabehfar) 's Twitter Profile Photo

Exciting new chapter for Reg Med in Rochester @mayoclinic. Bringing new hope for patients through cutting edge technology @dmcmn

michael yardley (@mdyardley) 's Twitter Profile Photo

Meet researcher Saad Kenderian: Using regenerative cell therapy to recognize and attack cancer | Mayo Clinic Center for Regenerative Medicine …generativemedicineblog.mayoclinic.org/2019/09/05/mee…

michael yardley (@mdyardley) 's Twitter Profile Photo

Researching Stem Cells for Kidney Disease: LaTonya Hickson, M.D. | Mayo Clinic Center for Regenerative Medicine …generativemedicineblog.mayoclinic.org/2019/09/12/res…

michael yardley (@mdyardley) 's Twitter Profile Photo

Regeneration for All | Mayo Clinic Center for Regenerative Medicine …generativemedicineblog.mayoclinic.org/2019/09/26/reg…

MayoRegMed (@mayoregmed) 's Twitter Profile Photo

Early animal studies Mayo Clinic are another step toward bioengineered human livers. Read about the research to find a solution to a shortage of #organdonations. mayocl.in/2D9R0CD

MayoRegMed (@mayoregmed) 's Twitter Profile Photo

A regenerative approach to facial surgery is offering new hope for restoring form and function for people who’ve suffered facial trauma or skin #cancer. mayocl.in/2XDVURy

Atta Behfar (@attabehfar) 's Twitter Profile Photo

A tremendous effort by many colleagues over 1 decade and spanning 2 continents to establish this paradigm - congratulations to the whole team!!

Atta Behfar (@attabehfar) 's Twitter Profile Photo

Excited to share this case report of PEP curing a non-healing radiation wound. Tremendous testament of Dr. Van Able's dedication to her patients and the Rion team's work to provide PEP exosomes for this clinical effort. nam12.safelinks.protection.outlook.com/?url=https%3A%…